Tasuku Yamamoto

Dr. Tasuku Yamamoto

orcid

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2024 in International Journal of Chronic Obstructive Pulmonary Disease
Verified
Journal Article
Open access
PDF file
TYTasuku Yamamoto
Tasuku Yamamoto
KOKeiji Oishi
Keiji Oishi
SOSyuichiro Ohata
Syuichiro Ohata
YMYoriyuki Murata
Yoriyuki Murata
YYYoshikazu Yamaji
Yoshikazu Yamaji
KMKazuto Matsunaga
Kazuto Matsunaga
Background: Reports from Europe and North America suggest that female chronic obstructive pulmonary disease (COPD) patients have a higher symptom burden and mortality than male patients. However, little is known about the management reality of female patients with COPD in Japan. Patients and Methods: We compared the clinical characteristics of female COPD patients with those of male using the cohort of the COPD Assessment in Practice study, which is a cross-sectional multicenter observational study. Results: Of the 1168 patients, 133 (11.4%) were female. A history of never smoking was higher in females than males (p< 0.01). Although there was no difference in age or forced expiratory volume in one second (FEV1) % predicted between the groups, modified medical research council dyspnea scale (mMRC) and number of frequent exacerbators were higher in females (mMRC≥ 2: p< 0.01; number of exacerbations≥ 2: p=0.011). The mean forced vital capacity and FEV1 values in females were lower than those in males (p< 0.0001 and p< 0.0001, respectively). Females were more likely to use long-term oxygen therapy and inhaled corticosteroids than males (p=0.016 and p< 0.01, respectively). The prevalence of the Global Initiative for Chronic Obstructive Lung Disease (GOLD) groups B, C, D (ABCD GOLD 2017 classification), and E (ABE GOLD 2023 classification) was higher in females than in males. Conclusion: The disease burden of female patients with COPD is higher than that of male patients in Japan, suggesting the importance of interventions considering female-dominant features such as lower absolute FVC and FEV1, respiratory failure, and asthma-like conditions.

1 September 2025 in International Journal of Chronic Obstructive Pulmonary Disease
Verified
Journal Article
Open access
PDF file
KHKazuki Hamada
Kazuki Hamada
KOKeiji Oishi
Keiji Oishi
TYTasuku Yamamoto
Tasuku Yamamoto
YMYoriyuki Murata
Yoriyuki Murata
MAMaki Asami-Noyama
Maki Asami-Noyama
KMKazuto Matsunaga
Kazuto Matsunaga
Purpose: Chronic obstructive pulmonary disease (COPD) is associated with frailty and leads to poor outcomes. The relationship between COPD and cardiovascular events is well established. However, the impact of frailty on cardiovascular events in COPD patients remains unknown. We aimed to evaluate the long-term association between frailty, assessed using the hospital frailty risk score (HFRS), and major adverse cardiovascular events (MACE) in COPD patients. Patients and Methods: We recruited Japanese patients with COPD between 2013 and 2023 from Sado-Himawari Net, a regional electronic health record system in Sado City, Niigata Prefecture, Japan. MACE were defined as a composite of acute coronary syndrome, heart failure, and stroke. We classified the participants into four frailty categories according to HFRS: no-frailty with HFRS=0, low with HFRS > 0 and < 5, intermediate with HFRS ≥ 5 and < 15, and high with HFRS ≥ 15. We used a Cox regression model adjusted for age, sex, inhaled treatments, and comorbidities to evaluate the hazard ratio (HR) for MACE. Results: We recruited 1527 patients with COPD. In multivariable analysis, COPD was associated with MACE as follows: no-frailty versus low HFRS (HR, 1.47 [95% confidence interval, 1.01– 2.14], p< 0.05), intermediate HFRS (HR 2.00 [1.34– 2.97], p< 0.001), and high HFRS (HR 2.62 [1.50– 4.59], p< 0.001). Similar relationships were observed even after adjusting for the severity of airflow limitation and COPD exacerbation. Conclusion: Frailty was independently associated with MACE in COPD patients during the 10-year follow-up period. Frailty assessment supports the identification of patients with COPD at risk of MACE.

28 November 2025 in Biomolecules
Verified
Journal Article
Open access
PDF file
KDKeiko Doi
Keiko Doi
THTsunahiko Hirano
Tsunahiko Hirano
NTNaoomi Tominaga
Naoomi Tominaga
KWKenji Watanabe
Kenji Watanabe
KOKeiji Oishi
Keiji Oishi
KMKazuto Matsunaga
Kazuto Matsunaga
Frailty is increasingly recognized as a systemic complication in patients with obstructive pulmonary diseases (OPDs), yet its molecular basis remains unclear. Extracellular vesicles (EVs), which transport small RNAs, may offer mechanistic insight into this comorbidity. This study investigated the association between serum-derived EV small RNAs and frailty in OPD. Sixty-eight patients with OPD were enrolled, and EVs isolated from 29 patients (13 with chronic obstructive pulmonary disease [COPD], four with COPD and asthma, and 12 with asthma; median age 72 years) were analyzed. Based on the Kihon Checklist, patients were classified as frail (n = 11) or non-frail (n = 18). Small RNA sequencing and differential expression analyses were conducted, followed by age-adjusted correlation with physical factors and Ingenuity Pathway Analysis (IPA). A total of 108 small RNAs were differentially expressed between frail and non-frail groups (p < 0.05, fold change < 0.8 or >1.2). IPA linked these RNAs to lung fibrosis and transforming growth factor-beta (TGF-β) signaling pathways. Eleven small RNAs correlated with lower limb strength, and three—miR-125b-5p, miR-369-3p, and miR-615-3p—emerged as key candidates associated with frailty. These findings suggest that EV-derived small RNAs may contribute to frailty development in OPD through TGF-β–related molecular mechanisms.

Verified
Journal Article
Open access
PDF file
KDKeiko Doi
Keiko Doi
YAYoshiyuki Asai
Yoshiyuki Asai
THTsunahiko Hirano
Tsunahiko Hirano
KOKeiji Oishi
Keiji Oishi
AFAyumi Fukatsu-Chikumoto
Ayumi Fukatsu-Chikumoto
KMKazuto Matsunaga
Kazuto Matsunaga
Background: Frailty impacts the prognosis of respiratory diseases but lacks standardized evaluation criteria. This pilot study aimed to develop a frailty assessment method using unsupervised clustering of various physical function tests. Methods: Clinical data, handgrip strength (HS), lower limb strength (LLS), the 6 min walk test (6 min WT), the 5 m walk test (5 m WT), body composition, such as skeletal muscle mass index (SMI), whole-body phase angle (WBPhA), and pulmonary function variables were measured. Frailty status was evaluated in three groups (frail, pre-frail, and robust) using the J-CHS and Kihon Checklist. Unsupervised hierarchical clustering was performed, followed by dimensionality reduction using Principal Component Analysis. Results: Ninety-eight patients and healthy volunteers (70 males, 28 females; mean age, 57.5 years) were divided into four clusters, ranging from robust to pronounced frailty. On the 2-principal component plane, data points formed clusters across the four regions. The biplot showed variables aggregating in two directions: one including %FEV1, FEV1%, 6 min WT, and 5 m WT speed (exercise tolerance), and the other including HS, LLS, SMI, and WBPhA (physical elements). Tracking 39 participants (mean, 636 days later) showed cluster shifts that were broadly reproducible, although the small follow-up sample warrants cautious interpretation. Conclusions: As an exploratory, hypothesis-generating pilot study with a small single-center sample, this novel frailty model may offer a more granular assessment to help guide management; however, external validation in larger cohorts is required before clinical application.

2 November 2026 in Respirology
Verified
Journal Article
Open access
TYTasuku Yamamoto
Tasuku Yamamoto
KHKazuki Hamada
Kazuki Hamada
YYYoshikazu Yamaji
Yoshikazu Yamaji
KDKeiko Doi
Keiko Doi
JSJunki Suizu
Junki Suizu
KMKazuto Matsunaga
Kazuto Matsunaga
Background and Objective: Sinonasal symptoms are common in chronic obstructive pulmonary disease (COPD); however, their clinical significance remains unclear. This study investigated whether patient‐reported sinonasal symptoms are associated with COPD exacerbation history and whether multidimensional patient‐reported outcome (PRO) assessment identifies a distinct sinonasal symptom–dominant phenotype. Methods: This multicenter cross‐sectional study included 442 patients with COPD. Sinonasal symptoms, COPD health status, and frailty were assessed using the 22‐item Sino‐Nasal Outcome Test (SNOT‐22), COPD Assessment Test (CAT), and Kihon Checklist (KCL), respectively. Associations between the SNOT‐22 scores and COPD exacerbation history or frailty were evaluated using logistic regression analysis. Domain‐level analyses were performed using the previously reported SNOT‐22 domains. PRO‐based phenotyping was performed using unsupervised k‐prototype clustering of the SNOT‐22, CAT, and KCL items. Results: Patient‐reported sinonasal symptoms were common, with discordance between patient and physician reports. Higher SNOT‐22 scores were associated with COPD exacerbation history and frailty. Domain‐level analyses showed that the nasal symptom domain was associated with exacerbation history, whereas the emotional domain was associated with frailty. PRO‐based clustering identified four clinically interpretable phenotypes, including a nasal symptom–dominant phenotype associated with COPD exacerbation history. Conclusion: Patient‐reported sinonasal symptoms are common and clinically relevant in COPD, with discordance between patient and physician reports. This study identified a nasal symptom–dominant phenotype associated with COPD exacerbation history, highlighting the potential value of upper airway assessment in personalized COPD management and suggesting that sinonasal symptoms may represent a candidate treatable trait.